Internal Medicine, Interventional Cardiology · Detroit, MI
NPI
1205874302
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
4160 John R St, Suite 724
Detroit, MI, 48201
Phone (313) 832-8888
Groups this clinician bills Medicare through
Medicare paid, 2024
$323K
4,193 services
Medicare patients, 2024
562
Average age 72
Drug cost, 2024
$2.2M
14,697 prescriptions
Company payments, 2025
$5,383
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Delair O Gardi was code 99213 (office e&m - established), 833 times for 396 patients. In total Delair O Gardi billed 4,193 services in 103 codes, and Medicare paid $323K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-12-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 833 | 396 | $60.24 | $50K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 288 | 72 | $4.72 | $1,359 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 172 | 86 | $91.24 | $16K |
| 93306 Echocardiography (TTE/TEE) | Office | 144 | 142 | $130.13 | $19K |
| 93000 Electrocardiogram | Office | 136 | 128 | $9.10 | $1,237 |
| 93015 Electrocardiogram | Office | 90 | 89 | $45.07 | $4,056 |
| 78452 Myocardial Perfusion Scan | Office | 86 | 86 | $309.58 | $27K |
| 99308 SNF E&M | Facility | 59 | 42 | $54.67 | $3,226 |
| 99214 Office E&M - Established | Office | 54 | 48 | $82.71 | $4,466 |
| 93970 Duplex Scan - Extremity Veins | Office | 53 | 53 | $129.04 | $6,839 |
| 93971 Duplex Scan - Extremity Veins | Office | 49 | 26 | $82.94 | $4,064 |
| 93290 External Electrocardiographic Monitoring | Office | 48 | 14 | $34.19 | $1,641 |
| 99232 Hospital E&M - Subsequent | Facility | 46 | 28 | $58.97 | $2,713 |
| 99204 Office E&M - New | Office | 38 | 38 | $101.62 | $3,862 |
| 36475 Varicose Vein Ablation | Office | 36 | 18 | $782.97 | $28K |
By year: 2022 $554K for 5,513 services; 2023 $357K for 3,937 services; 2024 $323K for 4,193 services.
Medicare prescription drug claims, 2024
In 2024, the drug Delair O Gardi prescribed most often to Medicare patients was Metoprolol Succinate, with 1,925 prescriptions and refills. In total Delair O Gardi wrote 14,697 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,925 | 4,224 | 565 | $23K |
| Atorvastatin Calcium Generic | 1,158 | 2,729 | 372 | $12K |
| Amlodipine Besylate Generic | 917 | 1,941 | 255 | $5,115 |
| Clopidogrel Clopidogrel Bisulfate | 869 | 2,020 | 256 | $12K |
| Losartan Potassium Generic | 784 | 1,730 | 226 | $6,528 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 749 | 1,550 | 194 | $9,167 |
| Nitroglycerin Generic | 639 | 789 | 202 | $12K |
| Eliquis Apixaban | 578 | 968 | 149 | $546K |
| Furosemide Generic | 552 | 1,080 | 154 | $1,982 |
| Spironolactone Generic | 531 | 1,074 | 161 | $4,454 |
| Carvedilol Generic | 478 | 1,012 | 133 | $3,880 |
| Hydrochlorothiazide Generic | 445 | 975 | 139 | $1,339 |
| Entresto Sacubitril/Valsartan | 441 | 762 | 119 | $494K |
| Xarelto Rivaroxaban | 413 | 715 | 98 | $381K |
| Metoprolol Tartrate Generic | 296 | 581 | 88 | $1,700 |
Brand drugs: 2,351 claims; generic drugs: 12,346 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Delair O Gardi $5,383 ($5,383 in general payments such as food, travel and fees) from 29 companies. The largest payer was Edwards Lifesciences Corporation with $1,429.
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation EW | 8 | $1,429 |
| Endologix LLC | 16 | $507 |
| Boston Scientific Corporation BSX | 18 | $387 |
| Alnylam Pharmaceuticals Inc. ALNY | 10 | $359 |
| AstraZeneca Pharmaceuticals LP AZN | 16 | $289 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $271 |
| Medtronic, Inc. MDT | 12 | $253 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $214 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $210 |
| Kestra Medical Technology Services, Inc. | 6 | $177 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.